Armaka M, Konstantopoulos D, Tzaferis C, et al (2021) Tunyogi-Csapo M, Kis-Toth K, Radacs M et al (2008) Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption
10.1016/j.cellsig.2023.110689 Summary Keywords clinical transition, dual inhibitors, phosphodiesterase 10A, phosphodiesterase 1B, schizophrenia Citation Rautela J, Gaurav A, Nissapatorn V, Tan CK, Girol AP, Pereira MDL and Lee VS (2026) PDE1B and PDE10A as novel targets for schizophrenia: from molecular design and synthesis to therapeutic promise
Available in box, push set and drip set good for 10 sessions
Maloberti, A
Three consecutive prolines at positions 35 (Pro-Pro-Pro) and an additional proline at position 8 create local conformational rigidity through the unique angle constraints of pyrrolidine-containing residues